[{"id":"995d0bdf-f601-4de6-b691-acef972a0188","acronym":"","url":"https://clinicaltrials.gov/study/NCT06163430","created_at":"2023-12-08T20:16:49.248Z","updated_at":"2024-07-02T16:35:26.721Z","phase":"Phase 1","brief_title":"CARDINAL- A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia","source_id_and_acronym":"NCT06163430","lead_sponsor":"Terns, Inc.","biomarkers":" ABL1 • BCR","pipe":"","alterations":" ","tags":["ABL1 • BCR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TERN-701"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 80","initiation":"Initiation: 12/13/2023","start_date":" 12/13/2023","primary_txt":" Primary completion: 11/30/2025","primary_completion_date":" 11/30/2025","study_txt":" Completion: 05/31/2026","study_completion_date":" 05/31/2026","last_update_posted":"2023-12-08"},{"id":"8d0c3a0e-31fd-4129-8881-4df591e7fa77","acronym":"","url":"https://clinicaltrials.gov/study/NCT05367700","created_at":"2022-05-10T20:53:40.639Z","updated_at":"2024-07-02T16:35:57.615Z","phase":"Phase 1","brief_title":"A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.","source_id_and_acronym":"NCT05367700","lead_sponsor":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","biomarkers":" ABL1 • BCR","pipe":" | ","alterations":" BCR-ABL1 fusion","tags":["ABL1 • BCR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BCR-ABL1 fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TERN-701"],"overall_status":"Recruiting","enrollment":" Enrollment 108","initiation":"Initiation: 04/28/2022","start_date":" 04/28/2022","primary_txt":" Primary completion: 12/30/2024","primary_completion_date":" 12/30/2024","study_txt":" Completion: 09/30/2026","study_completion_date":" 09/30/2026","last_update_posted":"2023-01-13"}]